8-K
filed June 29, 2023, 7:59 PM ET
ticker CADL
CIK 0001841387
other
confidence high
sentiment neutral
materiality 0.15
Candel Therapeutics stockholders elect three Class II directors and ratify KPMG as auditor at annual meeting
Candel Therapeutics, Inc.
- Elected Edward J. Benz Jr., Paul B. Manning, and Paul Peter Tak as Class II directors; each received over 10.7M votes for.
- Ratified KPMG as independent auditor for FY2023 with 15,388,012 for, 82,122 against, 1,081 abstain.
- Broker non-votes on director election totaled 4,502,642 shares.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Candel Therapeutics, Inc. shareholders approved Ratification of appointment of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-28 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-28
Exact text from the filing
The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, recommended for ratification in Proposal 2 at the Annual Meeting. The votes cast at the Annual Meeting were as follows: For Against Abstain 15,388,012 82,122 1,081
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Candel Therapeutics, Inc. shareholders approved Election of three Class II directors at the 2023-06-28 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-28
Exact text from the filing
The Company’s stockholders elected each of the Class II director nominees, Edward J. Benz Jr., M.D., Paul B. Manning, and Paul Peter Tak, M.D., Ph.D., FMedSci, recommended for election at the Annual Meeting in Proposal 1. The votes cast at the Annual Meeting were as follows: For Against Abstain Broker Non-Votes Edward J. Benz Jr., M.D. 10,762,707 205,866 - 4,502,642 Paul B. Manning 10,903,287 65,286 - 4,502,642 Paul Peter Tak, M.D., Ph.D., FMedSci 10,930,887 37,686 - 4,502,642
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.